Recent Advances in the Chemical Synthesis and Biological Activity of Phenolic Metabolites

Recent Advances in Polyphenol Research

Volumn 1, Issue , 2008, Pages 317-358

  Barron, Denis ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY;

PHENOLIC METABOLITES;

METABOLITES;

EID: 70349203587     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444302400.ch14     Document Type: Chapter

References (157)

1. Aasmundstad, T.A., Morland, J. & Paulsen, R.E. (1995). Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. Journal of Pharmacology and Experimental Therapeutics, 275, 435-441.
2. Abd El Mohsen, M.M., Kuhnle, G., Rechner, A.R. et al. (2002). Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radical Biology & Medicine, 33, 1693-1702.
3. Abe, K., Nakada, Y., Suzuki, A. & Yumioka, E. (1993). Biliary metabolites of hesperetin in rats. Shoyakugaku Zasshi, 47, 43-46.
4. Adamson, R.H., Bridges, J.W., Evans, M.E. & Williams, R.T. (1969). The role of gut bacteria in the aromatization of quinic acid in different species. Biochemical Journal, 112, 17P.
5. Aumont, V., Krisa, S., Battaglia, E. et al. (2001). Regioselective and stereospecific glucuronidation of trans- and cis-resveratrol in human. Archives of Biochemistry and Biophysics, 393, 281-289.
6. Awad, H.M., Boersma, M.G., Vervoort, J. & Rietjens, I.M.C.M. (2000). Peroxidase-catalyzed formation of quercetin quinone methide-glutathione adducts. Archives of Biochemistry and Biophysics, 378, 224-233.
7. Awad, H.M., Boersma, M.G., Boeren, S., Van Bladeren, P.J., Vervoort, J. & Rietjens, I.M.C.M. (2001). Structure-activity study on the quinone/quinone methide chemistry of flavonoids. Chemical Research in Toxicology, 14, 398-408.
8. Awad, H.M., Boersma, M.G., Boeren, S., Van Bladeren, P.J., Vervoort, J. & Rietjens, I.M.C.M. (2002). The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent. Chemical Research in Toxicology, 15, 343-351.
9. Barron, D. & Ibrahim, R.K. (1987). Synthesis of flavonoid sulfates. I. Stepwise sulfation of positions 3, 7, and 4' using N,W-dicyclohexylcarbodiimide and tetrabutylammonium hydrogen sulfate. Tetrahedron, 43, 5197-5202.
10. Barron, D. & Ibrahim, R.K. (1988a). Synthesis of flavonoid sulfates. II. The use of aryl sulfatase in the synthesis of flavonol 3-sulfates. Zeitschrift fuer Naturforschung, C: Journal of Biosciences, 43, 625-630.
11. Barron, D. & Ibrahim, R.K. (1988b). Synthesis of flavonoid sulfates. III. Synthesis of 3',4'-ortho disulfates using sulfur trioxide-trimethylamine complex, and of 3'-sulfates using aryl sulfatase. Zeitschrift fuer Naturforschung, C: Journal of Biosciences, 43, 631-635.
12. Barron, D., Varin, L., Ibrahim, R.K., Harborne, J.B. & Williams, C.A. (1988). Sulfated flavonoids - an update. Phytochemistry, 27, 2375-2395.
13. Barron, D., Cren-Olive, C. & Needs, P.W. (2003). Chemical synthesis of flavonoid conjugates. In: Methods in Polyphenol Analysis (eds C. Santos-Buelga & G. Williamson), pp. 187-213. The Royal Society of Chemistry, Cambridge, UK.
14. Basu-Modak, S., Gordon, M.J., Dobson, L.H., Spencer, J.P.E., Rice-Evans, C. & Tyrrell, R.M. (2003). Epicatechin and its methylated metabolite attenuate UVA-induced oxidative damage to human skin fibroblasts. Free Radical Biology & Medicine, 35, 910-921.
15. Begum, A.N. & Terao, J. (2002). Protective effect of quercetin against cigarette tar extract-induced impairment of erythrocyte deformability. Journal of Nutritional Biochemistry, 13, 265-272.
16. Berrín, J.G., McLauchlan, W.R., Needs, P. et al. (2002). Functional expression of human liver cytosolic ß-glucosidase in Pichia pastoris. Insights into its role in the metabolism of dietary glucosides. European Journal of Biochemistry, 269, 249-258.
17. Boersma, M.G., Vervoort, J., Szymusiak, H. et al. (2000). Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide. Chemical Research in Toxicology, 13, 185-191.
18. Boersma, B.J., Barnes, S., Kirk, M. et al. (2001). Soy isoflavonoids and cancer - metabolism at the target site. Mutation Research, 480-481, 121-127.
19. Boersma, M.G., van der Woude, H., Bogaards, J. et al. (2002). Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chemical Research in Toxicology, 15, 662-670.
20. Boersma, B.J., D'Alessandro, T., Benton, M.R. et al. (2003). Neutrophil myeloperoxidase chlorinates and nitrates soy isoflavones and enhances their antioxidant properties. Free Radical Biology & Medicine, 35, 1417-1430.
21. Booth, A.N., Emerson, O.H., Jones, F.T. & DeEds, F. (1957). Urinary metabolites of caffeic and chlorogenic acids. Journal of Biological Chemistry, 229, 51-59.
22. Bors, W., Heller, W., Michel, C. & Saran, M. (1990). Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Methods in Enzymology, 186, 343-355.
23. Browning, A.M., Walle, U.K. & Walle, T. (2005). Flavonoid glycosides inhibit oral cancer cell proliferation - role of cellular uptake and hydrolysis to the aglycones. Journal of Pharmacy and Pharmacology, 57, 1037-1041.
24. Cao, G., Sofic, E. & Prior, R.L. (1997). Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radical Biology & Medicine, 22, 749-760.
25. Cerda, B., Espin, J.C., Parra, S., Martinez, P. & Tomas-Barberan, F.A. (2004). The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolized into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. European Journal of Nutrition, 43, 205-220.
26. Chang, Q., Zuo, Z., Chow, M.S.S. & Ho, W.K.K. (2005). Difference in absorption of the two structurally similar flavonoid glycosides, hyperoside and isoquercitrin, in rats. European Journal of Pharmaceutics and Biopharmaceutics, 59, 549-555.
27. Chang, Y.C. & Nair, M.G. (1995). Metabolism of daidzein and genistein by intestinal bacteria. Journal of Natural Products, 58, 1892-1896.
28. Coldham, N.G., Howells, L.C., Santi, A. et al. (1999). Biotransformation of genistein in the rat: elucidation of metabolite structure by product ion mass fragmentology. Journal of Steroid Biochemistry and Molecular Biology, 70, 169-184.
29. Couteau, D., McCartney, A.L., Gibson, G.R., Williamson, G. & Faulds, C.B. (2001). Isolation and characterization of human colonic bacteria able to hydrolyse chlorogenic acid. Journal of Applied Microbiology, 90, 873-881.
30. Cren-Olive, C., Teissier, E., Duriez, P. & Rolando, C. (2003). Effect of catechin O-methylated metabolites and analogs on human LDL oxidation. Free Radical Biology & Medicine, 34, 850-855.
31. Crespy, V., Morand, C., Manach, C., Besson, C., Demigne, C. & Remesy, C. (1999). Part of quercetin absorbed in the small intestine is conjugated and further secreted in the intestinal lumen. American Journal of Physiology, 277, G120-G126.
32. Crespy, V., Morand, C., Besson, C., Manach, C., Demigne, C. & Remesy, C. (2002). Quercetin, but not its glycosides, is absorbed from the rat stomach. Journal of Agricultural and Food Chemistry, 50, 618-621.
33. Day, A.J., Bao, Y., Morgan, M.R.A. & Williamson, G. (2000). Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology & Medicine, 29, 1234-1243.
34. Day, A.J. & Williamson, G. (2001). Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma. British Journal of Nutrition, 86, S105-S110.
35. Day, A.J., Mellon, F., Barron, D., Sarrazin, G., Morgan, M.R.A. & Williamson, G. (2001). Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radical Research, 35, 941-952.
36. Day, A.J., Gee, J.M., DuPont, M.S., Johnson, I.T. & Williamson, G. (2003). Absorption of quercetin-3-glucoside and quercetin-4'-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochemical Pharmacology, 65, 1199-1206.
37. Deboves, H.J.C., Montalbetti, C.A.G.N. & Jackson, R.F.W. (2001). Direct synthesis of Fmoc- protected amino acids using organozinc chemistry: application to polymethoxylated phenylalanines and 4-oxoamino acids. Journal of the Chemical Society, Perkin Transactions 1, 1876-1884.
38. Donnini, S., Finetti, F., Lusini, L. et al. (2006). Divergent effects of quercetin conjugates on angiogenesis. British Journal of Nutrition, 95, 1016-1023.
39. Donovan, J.L., Crespy, V., Manach, C. et al. (2001). Catechin is metabolized by both the small intestine and liver of rats. Journal of Nutrition, 131, 1753-1757.
40. Dufour, C. & Dangles, O. (2005). Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy. Biochimica et Biophysica Acta, General Subjects, 1721, 164-173.
41. Gee, J.M., DuPont, M.S., Day, A.J., Plumb, G.W., Williamson, G. & Johnson, I.T. (2000). Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway. Journal of Nutrition, 130, 2765-2771.
42. Graefe, E.U. & Veit, M. (1999). Urinary metabolites of flavonoids and hydroxycinnamic acids in humans after application of a crude extract from Equisetum arvense. Phytomedicine, 6, 239-246.
43. 14C]quercetin-4'-glucoside in rats. Drug Metabolism and Disposition, 33, 1036-1043.
44. Guiso, M., Marra, C. & Farina, A. (2002). A new efficient resveratrol synthesis. Tetrahedron Letters, 43, 597-598.
45. Gyorgy, I., Antus, S., Blazovics, A. & Foldiak, G. (1992). Substituent effects in the free radical reactions of silybin: radiation-induced oxidation of the flavonoid at neutral pH. International Journal of Radiation Biology, 61, 603-609.
46. Heinonen, S., Nurmi, T., Liukkonen, K. et al. (2001). In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. Journal of Agricultural and Food Chemistry, 49, 3178-3186.
47. Hirota, S., Nishioka, T., Shimoda, T., Miura, K., Ansai, T. & Takahama, U. (2001). Quercetin glu- cosides are hydrolyzed to quercetin in human oral cavity to participate in peroxidase-dependent scavenging of hydrogen peroxide. Food Science and Technology Research, 7, 239-245.
48. Hollman, P.C.H., Bijsman, M.N.C.P., Van Gameren, Y., Cnossen, E.P.J., De Vries, J.H.M. & Katan, M.B. (1999). The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radical Research, 31, 569-573.
49. Hong, J., Lu, H., Meng, X., Ryu, J.H., Hara, Y. & Yang, C.S. (2002). Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Research, 62, 7241-7246.
50. Hong, J., Lambert, J.D., Lee, S.H., Sinko, P.J. & Yang, C.S. (2003). Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochemical and Biophysical Research Communications, 310, 222227.
51. Ireson, C., Orr, S., Jones, D.J.L. et al. (2001). Characterization of metabolites of the chemopre- ventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Research, 61, 1058-1064.
52. Ireson, C.R., Jones, D.J.L., Orr, S. et al. (2002). Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiology, Biomarkers & Prevention, 11, 105111.
53. Iwashita, K., Yamaki, K. & Tsushida, T. (2001). Effect of flavonoids on the differentiation of 3T3-L1 adipocytes. Food Science and Technology Research, 7, 154-160.
54. Janisch, K.M., Williamson, G., Needs, P. & Plumb, G.W. (2004). Properties of quercetin conjugates: Modulation of LDL oxidation and binding to human serum albumin. Free Radical Research, 38, 877-884.
55. Jones, D.J.L., Jukes-Jones, R., Verschoyle, R.D., Farmer, P.B. & Gescher, A. (2005). A synthetic approach to the generation of quercetin sulfates and the detection of quercetin 3'-O-sulfate as a urinary metabolite in the rat. Bioorganic & Medicinal Chemistry, 13, 6727-6731.
56. Jurd, L. (1962). Selective alkylation of polyphenols. II. Methylation of 7-, 4'-, and 3'-hydroxyl groups in flavonols. Journal of Organic Chemistry, 27, 1294-1297.
57. Justesen, U., Arrigoni, E., Larsen, B.R. & Amado, R. (2000). Degradation of flavonoid glycosides and aglycones during in vitro fermentation with human fecal flora. Lebensmittel-Wissenschaft und -Technologie, 33, 424-430.
58. Kaldas, M.I., Walle, U.K. & Walle, T. (2003). Resveratrol transport and metabolism by human intestinal Caco-2 cells. Journal of Pharmacy and Pharmacology, 55, 307-312.
59. Kaldas, M.I., Walle, U.K., van der Woude, H., McMillan, J.M. & Walle, T. (2005). Covalent binding of the flavonoid quercetin to human serum albumin. Journal of Agricultural and Food Chemistry, 53, 4194-4197.
60. Kanakubo, A., Koga, K., Isobe, M. et al. (2001). First finding of daidzein 7-O-phosphate and genis- tein 7-O-phosphate that are hydrolyzed by sulfatase. Tetrahedron, 57, 8801-8805.
61. Kern, S.M., Bennett, R.N., Needs, P.W., Mellon, F.A., Kroon, P.A. & Garcia-Conesa, M.T. (2003). Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium Caco-2 cells. Journal of Agricultural and Food Chemistry, 51, 7884-7891.
62. Kessler, M., Ubeaud, G. & Jung, L. (2002). Anti- and pro-oxidant activity of rutin and quercetin derivatives. Journal of Pharmacy and Pharmacology, 55, 131-142.
63. Kim, D.O. & Lee, C. (2004). Comprehensive study on vitamin C equivalent antioxidant capacity (VCEAC) of various polyphenolics in scavenging a free radical and its structural relationship. Critical Reviews in Food Science and Nutrition, 44, 253-273.
64. Konishi, Y. & Shimizu, M. (2003). Transepithelial transport of ferulic acid by monocarboxylic acid transporter in Caco-2 cell monolayers. Bioscience, Biotechnology, and Biochemistry, 67, 856-862.
65. Konishi, Y., Kobayashi, S. & Shimizu, M. (2003). Transepithelial transport of p-coumaric acid and gallic acid in Caco-2 cell monolayers. Bioscience, Biotechnology, and Biochemistry, 67, 2317-2324.
66. Konishi, Y. & Kobayashi, S. (2004a). Microbial metabolites of ingested caffeic acid are absorbed by the monocarboxylic acid transporter (MCT) in intestinal Caco-2 cell monolayers. Journal of Agricultural and Food Chemistry, 52, 6418-6424.
67. Konishi, Y. & Kobayashi, S. (2004b). Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal Caco-2 cell monolayers. Journal of Agricultural and Food Chemistry, 52, 2518-2526.
68. Konishi, Y., Zhao, Z. & Shimizu, M. (2006). Phenolic acids are absorbed from the rat stomach with different absorption rates. Journal of Agricultural and Food Chemistry, 54, 7539-7543.
69. Kren, V., Ulrichova, J., Kosina, P. et al. (2000). Chemoenzymatic preparation of silybin ß-glucuronides and their biological evaluation. Drug Metabolism and Disposition, 28, 1513-1517.
70. Kuhnle, G., Spencer, J.P.E., Schroeter, H. et al. (2000). Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochemical and Biophysical Research Communications, 277, 507-512.
71. Kulling, S.E., Honig, D.M., Simat, T.J. & Metzler, M. (2000). Oxidative in vitro metabolism of the soy phytoestrogens daidzein and genistein. Journal of Agricultural and Food Chemistry, 48, 4963-4972.
72. Kulling, S.E., Honig, D.M. & Metzler, M. (2001). Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo. Journal of Agricultural and Food Chemistry, 49, 3024-3033.
73. Learmonth, D.A. (2003). A concise synthesis of the 3-O-ß-D- and 4'-O-ß-D-glucuronide conjugates of trans-resveratrol. Bioconjugate Chemistry, 14, 262-267.
74. Lee, M.J., Maliakal, P., Chen, L. et al. (2002). Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiology, Biomarkers & Prevention, 11, 1025-1032.
75. Li, C., Lee, M.J., Sheng, S., Meng, X. et al. (2000). Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chemical Research in Toxicology, 13, 177-184.
76. Li, C., Meng, X., Winnik, B. et al. (2001). Analysis of urinary metabolites of tea catechins by liquid chromatography/electrospray ionization mass spectrometry. Chemical Research in Toxicology, 14, 702-707.
77. Lu, Y. & Foo, L.Y. (2001). Antioxidant activities of polyphenols from sage (Salvia officinalis). Food Chemistry, 75, 197-202.
78. Macdonald, I.A., Mader, J.A. & Bussard, R.G. (1983). The role of rutin and quercitrin in stimulating flavonol glycosidase activity by cultured cell-free microbial preparations of human feces and saliva. Mutation Research, 122, 95-102.
79. Manach, C., Morand, C., Crespy, V. et al. (1998). Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Letters, 426, 331-336.
80. Mateos, R., Goya, L. & Bravo, L. (2006). Uptake and metabolism of hydroxycinnamic acids (chlorogenic, caffeic, and ferulic acids) by HepG2 cells as a model of the human liver. Journal of Agricultural and Food Chemistry, 54, 8724-8732.
81. Matsuda, H., Morikawa, T., Toguchida, I. & Yoshikawa, M. (2002). Structural requirements of flavonoids and related compounds for aldose reductase inhibitory activity. Chemical & Pharmaceutical Bulletin, 50, 788-795.
82. Matsuda, H., Morikawa, T., Ando, S., Toguchida, I. & Yoshikawa, M. (2003a). Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorganic & Medicinal Chemistry, 11, 1995-2000.
83. Matsuda, H., Wang, T., Managi, H. & Yoshikawa, M. (2003b). Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorganic & Medicinal Chemistry, 11, 5317-5323.
84. Matsumoto, H., Ikoma, Y., Sugiura, M., Yano, M. & Hasegawa, Y. (2004). Identification and quantification of the conjugated metabolites derived from orally administered hesperidin in rat plasma. Journal of Agricultural and Food Chemistry, 52, 6653-6659.
85. Meng, X., Sang, S., Zhu, N. et al. (2002). Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chemical Research in Toxicology, 15, 1042-1050.
86. Miksits, M., Maier-Salamon, A., Aust, S. et al. (2005). Sulfation of resveratrol in human liver: Evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1. Xenobiotica, 35, 1101-1119.
87. Moon, J.H., Tsushida, T., Nakahara, K. & Terao, J. (2001). Identification of quercetin 3-O-ß-D- glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radical Biology & Medicine, 30, 1274-1285.
88. Morand, C., Crespy, V., Manach, C., Besson, C., Demigne, C. & Remesy, C. (1998). Plasma metabolites of quercetin and their antioxidant properties. American Journal of Physiology, 275, R212-R219.
89. Mulder, G.J. (1992). Pharmacological effects of drug conjugates: is morphine 6-glucuronide an exception? Trends in Pharmacological Sciences, 13, 302-304.
90. 14C] quercetin-4'-glucoside. Journal of Agricultural and Food Chemistry, 50, 6902-6909.
91. 14C-labelled flavonol metabolites by high-performance liquid chromatography-radiocounting and tandem mass spectrometry. Journal of Chromatography A, 1007, 21-29.
92. Nakazawa, T. & Ohsawa, K. (1998). Metabolism of rosmarinic acid in rats. Journal of Natural Products, 61, 993-996.
93. Narita, M., Nagai, E., Hagiwara, H., Aburada, M., Yokoi, T. & Kamataki, T. (1993). Inhibition of ß-glucuronidase by natural glucuronides of Kampo medicines using glucuronide of SN-38 (7- ethyl-10-hydroxycamptothecin) as a substrate. Xenobiotica, 23, 5-10.
94. Natsume, M., Osakabe, N., Oyama, M. et al. (2003). Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radical Biology & Medicine, 34, 840-849.
95. Natsume, M., Osakabe, N., Yasuda, A. et al. (2004). In vitro antioxidative activity of (-)-epicatechin glucuronide metabolites present in human and rat plasma. Free Radical Research, 38, 13411348.
96. Needs, P.W. & Kroon, P.A. (2006). Convenient syntheses of metabolically important quercetin glucuronides and sulfates. Tetrahedron, 62, 6862-6868.
97. Nemeth, K., Plumb, G.W., Berrín, J.G. et al. (2003). Deglycosylation by small intestinal epithelial cell ß-glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. European Journal of Nutrition, 42, 29-42.
98. Niemeyer, H.B., Honig, D., Lange-Boehmer, A., Jacobs, E., Kulling, S.E. & Metzler, M. (2000). Oxidative metabolites of the mammalian lignans enterodiol and enterolactone in rat bile and urine. Journal of Agricultural and Food Chemistry, 48, 2910-2919.
99. Okamura, N., Haraguchi, H., Hashimoto, K. & Yagi, A. (1994). Flavonoids in Rosmarinus officinalis leaves. Phytochemistry, 37, 1463-1466.
100. O'Leary, K.A., Day, A.J., Needs, P.W., Sly, W.S., O'Brien, N.M. & Williamson, G. (2001). Flavonoid glucuronides are substrates for human liver ß-glucuronidase. FEBS Letters, 503, 103-106.
101. O'Leary, K.A., Day, A.J., Needs, P.W., Mellon, F.A., O'Brien, N.M. & Williamson, G. (2003). Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human ß-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochemical Pharmacology, 65, 479-491.
102. O'Leary, K.A., Pascual-Teresa, S., Needs P.W., Bao, Y.P., O'Brien, N.M. & Williamson, G. (2004). Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutation Research, 551, 245-254.
103. Olthof, M.R., Hollman, P.C.H., Buijsman, M.N.C.P., van Amelsvoort, J.M.M. & Katan, M.B. (2003). Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. Journal of Nutrition, 133, 1806-1814.
104. Pan, M.H., Huang, T.M. & Lin, J.K. (1999). Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition, 27, 486-494.
105. Pascual-Teresa, S., Johnston, K.L., DuPont, M.S. et al. (2004). Quercetin metabolites downregu- late cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. Journal of Nutrition, 134, 552-557.
106. Pearson, A.G., Kiefel, M.J., Ferro, V. & von Itzstein, M. (2005). Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid. Carbohydrate Research, 340, 2077-2085.
107. Peterson, T.G., Coward, L., Kirk, M., Falany, C.N. & Barnes, S. (1996). The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis, 17, 1861-1869.
108. Petri, N., Tannergren, C., Holst, B. et al. (2003). Absorption/metabolism of sulforaphane and quercetin, and regulation of phase II enzymes, in human jejunum in vivo. Drug Metabolism and Disposition, 31, 805-813.
109. Plumb, G.W., Garcia-Conesa, M.T., Kroon, P.A., Rhodes, M., Ridley, S. & Williamson, G. (1999). Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora. Journal of the Science of Food and Agriculture, 79, 390-392.
110. Quick, A.J. (1931). The conjugation of benzoic acid in man. Journal of Biological Chemistry, 92, 65-85.
111. Rechner, A.R., Kuhnle, G., Bremner, P., Hubbard, G.P., Moore, K.P. & Rice-Evans, C.A. (2002). The metabolic fate of dietary polyphenols in humans. Free Radical Biology & Medicine, 33, 220-235.
112. Rechner, A.R., Smith, M.A., Kuhnle, G. et al. (2004). Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radical Biology & Medicine, 36, 212-225.
113. Rice-Evans, C.A., Miller, N.J. & Paganga, G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology & Medicine, 20, 933-956.
114. Rimbach, G., Weinberg, P.D., Pascual-Teresa, S. et al. (2004). Sulfation of genistein alters its antioxidant properties and its effect on platelet aggregation and monocyte and endothelial function. Biochimica et Biophysica Acta, General Subjects, 1670, 229-237.
115. Rios, L.Y., Bennett, R.N., Lazarus, S.A., Remesy, C., Scalbert, A. & Williamson, G. (2002). Cocoa procyanidins are stable during gastric transit in humans. American Journal of Clinical Nutrition, 76, 1106-1110.
116. Ruefer, C.E., Glatt, H. & Kulling, S.E. (2006). Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry. Drug Metabolism and Disposition, 34, 51-60.
117. Ruefer, C.E. & Kulling, S.E. (2006). Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. Journal of Agricultural and Food Chemistry, 54, 2926-2931.
118. Sai, Y., Kaneko, Y., Ito, S. et al. (2006). Predominant contribution of organic anion transporting polypeptide OATP-B (OATP2B1) to apical uptake of estrone-3-sulfate by human intestinal Caco- 2 cells. Drug Metabolism and Disposition, 34, 1423-1431.
119. 2-induced chromosomal damage to WIL2-NS cells. Bioscience, Biotechnology, and Biochemistry, 68, 271-276.
120. Schroeter, H., Spencer, J.P.E., Rice-Evans, C. & Williams R.J. (2001). Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochemical Journal, 358, 547-557.
121. Schroeter, H., Heiss, C., Balzer, J. et al. (2006). (-)-Epicatechin mediates beneficial effects of flavanol- rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences of the United States of America, 103, 1024-1029.
122. Shimizu, M., Ito, T., Terashima, S., et al. (1984). Inhibition of lens aldose reductase by flavonoids. Phytochemistry, 23, 1885-1888.
123. Shirai, M., Moon, J.H., Tsushida, T. & Terao, J. (2001). Inhibitory effect of a quercetin metabolite, quercetin 3-O-ß-D-glucuronide, on lipid peroxidation in liposomal membranes. Journal of Agricultural and Food Chemistry, 49, 5602-5608.
124. Shirai, M., Yamanishi, R., Moon, J.H., Murota, K. & Terao, J. (2002). Effect of quercetin and its conjugated metabolite on the hydrogen peroxide-induced intracellular production of reactive oxygen species in mouse fibroblasts. Bioscience, Biotechnology, and Biochemistry, 66, 1015-1021.
125. Spencer, J.P.E., Chaudry, F., Pannala, A.S., Srai, S.K., Debnam, E. & Rice-Evans, C. (2000). Decomposition of cocoa procyanidins in the gastric milieu. Biochemical and Biophysical Research Communications, 272, 236-241.
126. Spencer, J.P.E., Schroeter, H., Crossthwaithe, A.J., Kuhnle, G., Williams, R.J. & Rice-Evans, C. (2001a). Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radical Biology & Medicine, 31, 1139-1146.
127. Spencer, J.P.E., Schroeter, H., Kuhnle, G. et al. (2001b). Epicatechin and its in vivo metabolite, 3'-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochemical Journal, 354, 493-500.
128. Spencer, J.P.E., Kuhnle, G.G.C., Williams, R.J. & Rice-Evans, C. (2003a). Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochemical Journal, 372, 173-181.
129. Spencer, J.P.E., Rice-Evans, C. & Williams, R.J. (2003b). Modulation of pro-survival Akt/Protein Kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlies their action on neuronal viability. Journal of Biological Chemistry, 278, 34783-34793.
130. Stachulski, A.V. & Jenkins, G.N. (1998). The synthesis of O-glucuronides. Natural Product Reports, 15, 173-186.
131. Su, Y.L., Xu, J.Z., Ng, C.H., Leung, L.K., Huang, Y. & Chen, Z.Y. (2004). Antioxidant activity of tea theaflavins and methylated catechins in canola oil. Journal of the American Oil Chemists' Society, 81, 269-274.
132. Sugiyama, Y., Kawakishi, S. & Osawa, T. (1996). Involvement of the ß-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochemical Pharmacology, 52, 519-525.
133. Takamatsu, S., Galal, A.M., Ross, S.A. et al. (2003). Antioxidant effect of flavonoids on DCF production in HL-60 cells. Phytotherapy Research, 17, 963-966.
134. Terao, J., Yamaguchi, S., Shirai, M. et al. (2001). Protection by quercetin and quercetin 3-O-ß-D- glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radical Research, 35, 925-931.
135. Tsang, C., Auger, C., Mullen, W. et al. (2005). The absorption, metabolism and excretion of flavan- 3-ols and procyanidins following the ingestion of a grape seed extract by rats. British Journal of Nutrition, 94, 170-181.
136. Tsatsanis, C., Androulidaki, A., Venihaki, M. & Margioris, A.N. (2006). Signaling networks regulating cyclooxygenase-2. International Journal of Biochemistry & Cell Biology, 38, 1654-1661.
137. Turner, R., Baron, T., Wolffram, S. et al. (2004). Effect of circulating forms of soy isoflavones on the oxidation of low density lipoprotein. Free Radical Research, 38, 209-216.
138. Vaidyanathan, J.B. & Walle, T. (2001). Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharmaceutical Research, 18, 1420-1425.
139. Vaidyanathan, J.B. & Walle, T. (2003). Cellular uptake and efflux of the tea flavonoid (-)- epicatechin-3-gallate in the human intestinal cell line Caco-2. Journal of Pharmacology and Experimental Therapeutics, 307, 745-752.
140. van der Woude, H., Boersma, M.G., Vervoort, J. & Rietjens, I.M.C.M. (2004). Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chemical Research in Toxicology, 17, 1520-1530.
141. van der Woude, H., Alink, G.M., Van Rossum, B.E.J. et al. (2005). Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity. Chemical Research in Toxicology, 18, 1907-1916.
142. van der Woude, H., Boersma, M.G., Alink, G.M., Vervoort, J. & Rietjens, I.M.C.M. (2006). Consequences of quercetin methylation for its covalent glutathione and DNA adduct formation. Chemico-Biological Interactions, 160, 193-203.
143. Walgren, R.A., Lin, J.T., Kinne, R.K. & Walle, T. (2000a). Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1. The Journal of Pharmacology and Experimental Therapeutics, 294, 837-843.
144. Walgren, R.A., Karnaky, K.J., Jr., Lindenmayer, G.E. & Walle, T. (2000b). Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. The Journal of Pharmacology and Experimental Therapeutics, 294, 830-836.
145. Walle, U.K., French, K.L., Walgren, R.A. & Walle, T. (1999). Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2. Research Communications in Molecular Pathology and Pharmacology, 103, 45-56.
146. Walle, T., Vincent, T.S. & Walle, U.K. (2003). Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochemical Pharmacology, 65, 1603-1610.
147. Walle, T., Browning, A.M., Steed, L.L., Reed, S.G. & Walle, U.K. (2005). Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. Journal of Nutrition, 135, 4852.
148. Wang, L.X., Heredia, A., Song, H. et al. (2004). Resveratrol glucuronides as the metabolites of resveratrol in humans: Characterization, synthesis, and anti-HIV activity. Journal of Pharmaceutical Sciences, 93, 2448-2457.
149. Watanabe, H., Yashiro, T., Tohjo, Y. & Konishi, Y. (2006). Non-involvement of the human monocarboxylic acid transporter 1 (MCT1) in the transport of phenolic acid. Bioscience, Biotechnology, and Biochemistry, 70, 1928-1933.
150. Wenzel, E., Soldo, T., Erbersdobler, H. & Somoza, V. (2005). Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Molecular Nutrition & Food Research, 49, 482-494.
151. Whitley, A.C., Sweet, D.H. & Walle, T. (2005). The dietary polyphenol ellagic acid is a potent inhibitor of hOAT1. Drug Metabolism and Disposition, 33, 1097-1100.
152. Williamson, G., Barron, D., Shimoi, K. & Terao, J. (2005). In vitro biological properties of flavonoid conjugates found in vivo. Free Radical Research, 39, 457-469.
153. Yang, J.H., Hsia, T.C., Kuo, H.M. et al. (2006). Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis. Drug Metabolism and Disposition, 34, 296-304.
154. Yoshikawa, M., Morikawa, T., Murakami, T., Toguchida, I., Harima, S. & Matsuda, H. (1999). Medicinal flowers. I. Aldose reductase inhibitors and three new eudesmane-type sesquiterpenes, kikkanols A, B, and C, from the flowers of Chrysanthemum indicum L. Chemical & Pharmaceutical Bulletin, 47, 340-345.
155. Yoshizumi, M., Tsuchiya, K., Suzaki, Y. et al. (2002). Quercetin glucuronide prevents VSMC hypertrophy by angiotensin II via the inhibition of JNK and AP-1 signaling pathway. Biochemical and Biophysical Research Communications, 293, 1458-1465.
156. Zhang, Z., Yu, B. & Schmidt, R.R. (2006). Synthesis of mono- and di-O-ß-D-glucopyranoside conjugates of (Æ')-resveratrol. Synthesis, 8, 1301-1306.
157. Zhu, Q.Y., Schramm, D.D., Gross, H.B. et al. (2005). Influence of cocoa flavanols and pro- cyanidins on free radical-induced human erythrocyte hemolysis. Clinical & Developmental Immunology, 12, 27-34.